ArticleCentral-European journal of immunology2025
Potential of miR-192-5p as a diagnostic marker for children with severe pneumonia and respiratory failure and its predictive value for prognosis.
Article in Central-European journal of immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- MiR-100-5p is involved in severe pneumonia in children by targeting MTOR.BMC immunology · 2026Article
- MIR210HG promotes the progression of pediatric pneumonia by inducing apoptosis and inflammation through downregulating miR-195-5p and upregulating FGF2.BMC pediatrics · 2026Article
- Diagnostic Value of miR-192-5p in the Progression of Chronic Obstructive Pulmonary Disease Complicated with Pulmonary Heart Disease.International journal of chronic obstructive pulmonary disease · 2026Article
- The diagnostic and prognostic value of circulating miR-193b-3p on severe pneumonia.BMC immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Severe pneumonia in children is a rapidly progressing respiratory system disease. If not promptly controlled, it can lead to respiratory failure, posing a serious threat to the child's life. This study investigated the diagnostic and prognostic potential of miR-192-5p in children with severe pneumonia and respiratory failure. Material and methods: A total of 62 children with severe pneumonia, 40 children with severe pneumonia and respiratory failure, and 62 healthy children were enrolled. The level of miR-192-5p was quantified by RT-qPCR assays. The diagnostic potential of miR-192-5p for severe pneumonia and respiratory failure was assessed through ROC curve and binary logistic analyses. The association between abnormal miR-192-5p level and prognosis of children with severe pneumonia with respiratory failure was evaluated by Kaplan-Meier and multivariate Cox analysis. Results: miR-192-5p expression was decreased in the serum of severe pneumonia and expiratory failure children. miR-192-5p has a good potential to predict the occurrence of severe pneumonia, which is a risk predictor of severe pneumonia in children with respiratory failure. In addition, downregulation of miR-192-5p was strongly associated with poor prognosis of children with severe pneumonia and respiratory failure. Conclusions: A low level of miR-192-5p has high predictive value and clinical development potential for the timely diagnosis and prediction of poor prognosis of children with severe pneumonia and respiratory failure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.